Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 7471 to 7485 of 8219 results

  1. Testing strategies for Lynch syndrome in people with endometrial cancer (DG42)

    We have moved Diagnostics guidance 42 to become HealthTech guidance 557. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment programme, Interventional Procedures programme and Medical Technologies Evaluation programme and to help you find relevant content more quickly. The guidance itself has not changed.

    Diagnostics guidance
    Published
    28 October 2020

  2. QAngio XA 3D QFR and CAAS vFFR imaging software for assessing coronary stenosis during invasive coronary angiography (DG43)

    We have moved Diagnostics guidance 43 to become HealthTech guidance 571. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment programme, Interventional Procedures programme and Medical Technologies Evaluation programme and to help you find relevant content more quickly. The guidance itself has not changed.

    Diagnostics guidance
    Published
    17 March 2021

  3. SeHCAT (tauroselcholic [75 selenium] acid) for diagnosing bile acid diarrhoea (DG44)

    We have moved Diagnostics guidance 44 to become HealthTech guidance 598. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment programme, Interventional Procedures programme and Medical Technologies Evaluation programme and to help you find relevant content more quickly. The guidance itself has not changed.

    Diagnostics guidance
    Published
    17 November 2021

  4. Atrial fibrillation and heart valve disease: self-monitoring coagulation status using point-of-care coagulometers (the CoaguChek XS system) (DG14)

    We have moved Diagnostics guidance 14 to become HealthTech guidance 353. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment programme, Interventional Procedures programme and Medical Technologies Evaluation programme and to help you find relevant content more quickly. The guidance itself has not changed.

    Diagnostics guidance
    Last updated
    19 December 2017

  5. The EOS 2D/3D imaging system (DG1)

    We have moved Diagnostics guidance 1 to become HealthTech guidance 274. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment programme, Interventional Procedures programme and Medical Technologies Evaluation programme and to help you find relevant content more quickly. The guidance itself has not changed.

    Diagnostics guidance
    Published
    26 October 2011

  6. Faecal calprotectin diagnostic tests for inflammatory diseases of the bowel (DG11)

    We have moved Diagnostics guidance 11 to become HealthTech guidance 320. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment programme, Interventional Procedures programme and Medical Technologies Evaluation programme and to help you find relevant content more quickly. The guidance itself has not changed.

    Diagnostics guidance
    Published
    2 October 2013

  7. Myocardial infarction (acute): Early rule out using high-sensitivity troponin tests (Elecsys Troponin T high-sensitive, ARCHITECT STAT High Sensitive Troponin-I and AccuTnI+3 assays) (DG15)

    This guidance has been updated and replaced by NICE HealthTech guidance 552.

    Diagnostics guidance
    Published
    1 October 2014

  8. Procalcitonin testing for diagnosing and monitoring sepsis (ADVIA Centaur BRAHMS PCT assay, BRAHMS PCT Sensitive Kryptor assay, Elecsys BRAHMS PCT assay, LIAISON BRAHMS PCT assay and VIDAS BRAHMS PCT assay) (DG18)

    We have moved Diagnostics guidance 18 to become HealthTech guidance 386. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment programme, Interventional Procedures programme and Medical Technologies Evaluation programme and to help you find relevant content more quickly. The guidance itself has not changed.

    Diagnostics guidance
    Published
    7 October 2015

  9. SeHCAT (tauroselcholic [75 selenium] acid) for the investigation of diarrhoea due to bile acid malabsorption in people with diarrhoea-predominant irritable bowel syndrome (IBS-D) or Crohn's disease without ileal resection (DG7)

    This guidance has been updated and replaced by NICE healthtech guidance 598.

    Diagnostics guidance
    Published
    28 November 2012

  10. The BCM – Body Composition Monitor for managing fluid in people having dialysis (MIB41)

    This advice has been updated and replaced by NICE guidance HTG441 

    Medtech innovation briefing
    Published
    13 October 2015

  11. Point-of-care diagnostic testing in primary care for strep A infection in sore throat (MIB145)

    This advice has been updated and replaced by NICE HealthTech guidance 531.

    Medtech innovation briefing
    Published
    2 May 2018

  12. QAngio XA 3D/QFR imaging software for assessing coronary obstructions (MIB146)

    This advice has been updated and replaced by NICE healthtech guidance 571.

    Medtech innovation briefing
    Published
    15 May 2018

  13. Point-of-care creatinine tests before contrast-enhanced imaging (MIB136)

    This advice has been replaced by NICE HealthTech guidance 530.

    Medtech innovation briefing
    Published
    18 January 2018

  14. Reveal LINQ insertable cardiac monitor to detect atrial fibrillation after cryptogenic stroke (MIB141)

    This advice has been updated and replaced by NICE healthtech guidance 553.

    Medtech innovation briefing
    Published
    16 February 2018

  15. NephroCheck test to help assess the risk of acute kidney injury in critically ill patients (MIB156)

    This medtech innovation briefing has been updated and replaced by NICE HealthTech guidance 544.

    Medtech innovation briefing
    Published
    24 August 2018